1. Home
  2. AVTR

as 07-26-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.

Founded: 1904 Country:
United States
United States
Employees: N/A City: RADNOR
Market Cap: 14.7B IPO Year: 2019
Target Price: $25.94 AVG Volume (30 days): 13.5M
Analyst Decision: Buy Number of Analysts: 18
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.38 EPS Growth: -58.70
52 Week Low/High: $16.63 - $26.16 Next Earning Date: 07-26-2024
Revenue: $6,866,700,000 Revenue Growth: -6.48%
Revenue Growth (this year): 1.55% Revenue Growth (next year): 5.61%

AVTR Daily Stock ML Predictions

Stock Insider Trading Activity of Avantor Inc. (AVTR)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Eck Steven W AVTR SVP & Chief Accounting Officer Mar 8 '24 Sell $25.63 3,685 $94,446.55 34,406 SEC Form 4
Couturier Christophe AVTR EVP, AMEA Feb 29 '24 Sell $24.53 13,074 $320,705.22 83,889 SEC Form 4
Bramwell James AVTR EVP Sales, Customer Excellence Feb 29 '24 Sell $24.52 4,910 $120,393.20 96,233 SEC Form 4
Bramwell James AVTR EVP Sales, Customer Excellence Feb 23 '24 Sell $24.49 6,203 $151,911.47 101,143 SEC Form 4

Share on Social Networks: